Ling-Wei Wang

机构：Guangdong Medical College, ShenZhen People’s Hospital, Affiliated Hospital of Guangdong Medical College Hospital

发表论文 7 篇 · 总被引 64 次 · h-index 4

代表论文

• Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study (2025 · The Lancet Respiratory Medicine · 被引 32)
• The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational study (2022 · Respiratory Research · 被引 13)
• Airway acidification impaired host defense against Pseudomonas aeruginosa infection by promoting type 1 interferon β response (2022 · Emerging Microbes & Infections · 被引 12)
• A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution forPseudomonas aeruginosaeradication in bronchiectasis: ERASE (2024 · ERJ Open Research · 被引 7)
• The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational study (2022 · Research Square)
• Control of chronic obstructive pulmonary disease in urban populations: findings from a cross-sectional prevalence survey in Shenzhen, China (2021 · Research Square)